Our integrated technology platforms can enable an unprecedented breadth of advanced therapies, including gene therapies, autologous and allogeneic cell therapies, and induced pluripotent stem cells (iPSCs)-derived regenerative therapies.
Learn more about
We have a powerful suite of gene editing technologies to accelerate the development of life-changing and curative therapies for patients. We aspire to broadly apply and make accessible a broad spectrum of editing modalities, including double-strand breaks, base editing, and prime editing to modify gene targets both in vivo and ex vivo. We have both viral and non-viral delivery platforms to effectively deliver gene and RNA-based therapies, unlocking new possibilities for addressing a wide range of diseases and disorders.
Our Therapeutic Approaches
We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.
We help our partners scale new heights in cell and gene therapies by providing a full spectrum of viral vector and cell therapy capabilities to bring concepts to commercialization.
Team of Industry-Leading Experts
We have assembled a leading team of experts with first-hand experience in the discovery, development, and manufacturing of cell and gene therapies. Driven by a common mission to power life-changing therapies, the team works to advance discoveries and development at a speed the world demands.
Partner with ElevateBio®
Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us